✦ LIBER ✦

Remission of resistant MPGN type I with mycophenolate mofetil and steroids

✍ Scribed by Sudarsana De; Dana Al-Nabhani; Paul Thorner; Daniel Cattran; Tino D. Piscione; Christoph Licht

Publisher: Springer
Year: 2009
Tongue: English
Weight: 260 KB
Volume: 24
Category: Article
ISSN: 0931-041X
DOI: 10.1007/s00467-008-1023-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of mycophenolate mofetil for st

Efficacy of mycophenolate mofetil for steroid and cyclosporine resistant membranoproliferative glomerulonephritis type

✍ Shuichi Ito; Akiko Tsutsumi; Aya Inaba; Hiroyuki Machida; Tomonori Harada; Shump 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 116 KB

Use of mycophenolate mofetil in steroid-

Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome

✍ Gina-Marie Barletta; William E. Smoyer; Timothy E. Bunchman; Joseph T. Flynn; Da 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 146 KB

Treatment of systemic lupus erythematosu

Treatment of systemic lupus erythematosus–associated type B insulin resistance syndrome with cyclophosphamide and mycophenolate mofetil

✍ Anil Gehi; Allison Webb; Martha Nolte; John Davis Jr. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 224 KB 👁 1 views

## Abstract Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of immunologic self‐tolerance and the subsequent development of autoantibodies. These antibodies are thought to be important in relation to the clinical manifestations of the disease. One example is the de

Steroid resistance in prolonged type I m

Steroid resistance in prolonged type I membranoproliferative glomerulonephritis and accelerated disease remission after steroid withdrawal

✍ Itsuro Kazama; Mitsunobu Matsubara; Yutaka Ejima; Mari Michimata; Michiko Suzuki 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 388 KB

Mycophenolate mofetil therapy in frequen

Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions

✍ Asha Moudgil; Arvind Bagga; Stanley C. Jordan 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 133 KB

Treatment of atopic eczema with oral myc

Treatment of atopic eczema with oral mycophenolate mofetil

✍ K. Neuber; I. Schwartz; G. Itschert; A.tom Dieck 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB

## Background: Activated t and b lymphocytes are the predominant inflammatory cells in atopic eczema (ae) lesions. mycophenolic acid, the active form of mycophenolate mofetil (mmf), blocks the proliferative responses of t and b lymphocytes. ## Objectives: In this pilot study, we examined the effi